Equillium’s phase 3 graft-versus-host disease (GVHD) trial has missed its primary endpoint and two key secondary objectives.

Fully enrolled LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients with mCRPCInitiating ...

Primary immunodeficiencies are not as rare as they used to be, James Fernandez, MD, PhD, told Healio, and practicing ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

Primary antibody deficiencies (PADs ... to rule out acute endocrine disorders secondary to current inflammation. Serum ACTH, cortisol, FSH, LH, prolactin, SHBG and TSH (Immulite 2000 XPi, Siemens AG), ...

If someone has two different forms of coverage, the primary payer covers most costs, and the secondary payer then steps in to cover some or all remaining expenses. With Medicare, secondary payers ...

A new report that used GOV.UK data to rank schools has looked at the 'best' primary and secondary performances in Cornwall. This report has been put together by Online Marketing Surgery and ...

Topline data from Phase 3 study in patients with Tourette syndrome shows statistical significance between ecopipam and placebo for both the primary efficacy endpoint in pediatric subjects (p = 0.0084) ...

Antibodies are one of the most specific tools for the detection and capture of molecular targets­­. The right antibody can play a key role in revealing the presence, quantity, dynamics, and even ...